Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals
Jae Cheon Kim, Eun Ji Park, Dong Hee Na
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1585-1585
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives
Bingwen Ding, Zhu Zhu, Cong Guo, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2006-2025
Open Access | Times Cited: 9
Challenges and opportunities in delivering oral peptides and proteins
Haisheng Peng, Jiahe Wang, Jiayu Chen, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 10, pp. 1349-1369
Open Access | Times Cited: 14
Applications and Challenges of Oral Peptide Drug Delivery in Diabetes Treatment
Yuchen Feng
Theoretical and Natural Science (2025) Vol. 68, Iss. 1, pp. 234-244
Open Access
Design, evaluation, and in vitro–in vivo correlation of self-nanoemulsifying drug delivery systems to improve the oral absorption of exenatide
Ramakrishnan Venkatasubramanian, Passant M. Al-Maghrabi, Oscar Alavi, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 440-451
Open Access
Bioactive nanomotor enabling efficient intestinal barrier penetration for colorectal cancer therapy
Zhi‐Hao Wang, Xuejiao Zeng, Wanting Huang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Oral delivery of biomacromolecules by overcoming biological barriers in the gastrointestinal tract: an update
Shiyun Liu, Xiangce Wen, Xin Zhang, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 10, pp. 1333-1347
Closed Access | Times Cited: 12
Peptide mapping analysis of synthetic semaglutide and liraglutide for generic development of drugs originating from recombinant DNA technology
Soo Hyun Kim, Sung Soo Kim, Hyun Jun Kim, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 256, pp. 116682-116682
Closed Access
Harnessing the Potential of Human Breast Milk to Boost Intestinal Permeability for Nanoparticles and Macromolecules
Si Naftaly, Tal Pery, Rawan Mhajne, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 768-785
Open Access
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases
Qiuxia Jiao, Yuan Huang, Jinhan He, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 238-238
Open Access
Carnitine Deficiency Caused by Salcaprozic Acid Sodium Contained in Oral Semaglutide in a Patient with Multiple Acyl-CoA Dehydrogenase Deficiency
Yasuko Mikami-Saito, Masamitsu Maekawa, Masahiro Watanabe, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2962-2962
Open Access
Linoleic acid co-administration promotes oral delivery of exenatide-loaded butyrate-decorated nanocapsules
Haoyang Yuan, Peifu Xiao, Handong Wang, et al.
Journal of Controlled Release (2025), pp. 113744-113744
Closed Access
Oral proniosomal amitriptyline and liraglutide for management of diabetic neuropathy: Exceptional control over hyperglycemia and neuropathic pain
Rana G. Eissa, Noura G. Eissa, Rana A. Eissa, et al.
International Journal of Pharmaceutics (2023) Vol. 647, pp. 123549-123549
Closed Access | Times Cited: 9
Pharmacotherapy of Weight‐loss and Obesity with a Focus on GLP 1‐Receptor Agonists
Merle Myerson, Rodis Paparodis
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 10, pp. 1204-1221
Closed Access | Times Cited: 3
Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs
Daigo Asano, Hideo Takakusa, Daisuke Nakai
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 47-47
Open Access | Times Cited: 8
A Comprehensive Review of Challenges in Oral Drug Delivery Systems and Recent Advancements in Innovative Design Strategies
Ying Hui Loke, Achuth Jayakrishnan, Muhammad Redza Fahmi Mod Razif, et al.
Current Pharmaceutical Design (2024) Vol. 31, Iss. 5, pp. 360-376
Closed Access | Times Cited: 2
Compounded peptides: An Obesity Medicine Association Position Statement
Angela Fitch, Anthony Auriemma, Harold Bays
Obesity Pillars (2023) Vol. 6, pp. 100061-100061
Open Access | Times Cited: 5
Neonatal intestinal mucus barrier changes in response to maturity, inflammation, and sodium decanoate supplementation
Janni Støvring Mortensen, Søren S.-R. Bohr, L Krog, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Intestinal Lymphatic Biology, Drug Delivery and Therapeutics: Current status and Future directions
Sanjeevini Babu Reddiar, Yining Xie, Mohammad Abdallah, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 1326-1398
Open Access | Times Cited: 1
Buccal Absorption of Biopharmaceutics Classification System III Drugs: Formulation Approaches and Mechanistic Insights
Rayan Sabra, Daniel Kirby, Vikram Chouk, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1563-1563
Open Access | Times Cited: 1
Evaluation of Biologics ACE2/Ang(1–7) Encapsulated in Plant Cells for FDA Approval: Safety and Toxicology Studies
Henry Daniell, Geetanjali Wakade, Smruti K. Nair, et al.
Pharmaceutics (2024) Vol. 17, Iss. 1, pp. 12-12
Open Access | Times Cited: 1
The Importance of Drug Delivery in the Clinical Development and Lifecycle of Drug Products with Examples from Authorised Medicinal Products
Maria Malamatari
Processes (2023) Vol. 11, Iss. 10, pp. 2919-2919
Open Access | Times Cited: 3
Salcaprozate-based ionic liquids for GLP-1 gastric delivery: A mechanistic understanding of in vivo performance
René Rebollo, Zhigao Niu, Lasse Ingerslev Blaabjerg, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 267-276
Open Access
Advances in the Oral Administration of Somatostatin Receptor Ligands in Acromegaly: A Systematic Review Focusing on Biochemical Response
Clémence Reverdiau, Damien Denimal
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1357-1357
Open Access
Dendrimer nanoplatforms for oral drug delivery applications
Dohyun Kim, Sungjun Kim, Dong Hee Na
Journal of Pharmaceutical Investigation (2024)
Closed Access
Are membrane-interacting peptides viable as excipients for non-injectable peptide delivery?
Hanne Mørck Nielsen
Expert Opinion on Drug Delivery (2024), pp. 1-4
Open Access
Page 1 - Next Page

Scroll to top